Dr Theresa Erin Yurkonis, DO | |
2500 Bernville Rd, Reading, PA 19605-9453 | |
(610) 378-2000 | |
(610) 378-2799 |
Full Name | Dr Theresa Erin Yurkonis |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 8 Years |
Location | 2500 Bernville Rd, Reading, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164876306 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
St Joseph Medical Center | Reading, PA | Hospital |
Milton S Hershey Medical Center | Hershey, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Joseph Medical Group | 3779688650 | 171 |
St Joseph Regional Health Network | 1658289517 | 21 |
News Archive
By shifting a normal protective mechanism into overdrive, a University of Wisconsin-Madison scientist has completely shielded mice from a toxic chemical that would otherwise cause Parkinson's disease.
Scientists have identified a channel present in many pain detecting sensory neurons that acts as a 'brake', limiting spontaneous pain. It is hoped that the new research, published today [22 January] in the Journal of Neuroscience, will ultimately contribute to new pain relief treatments.
"The National Institutes of Health announced Tuesday that it has suspended funding new human embryonic stem cell research and that all federally funded experiments already underway will be cut off when they come up for renewal if a new court order is not overturned. The announcement - which confirmed fears among proponents that the ruling would result in a comprehensive freeze in federal support for stem cell research - came in response to a court order Monday barring the government from funding the research because it involves the destruction of embryos.
Today, the International and American Associations for Dental Research (IADR/AADR) published a paper titled "-catenin is Required in Odontoblasts for Tooth Root Formation." The paper, written by lead authors Tak-Heun Kim and Cheol-Hyeon Bae, Chonbuk National University Korea School of Dentistry, Laboratory for Craniofacial Biology, is published in the IADR/AADR Journal of Dental Research.
US-based pharmaceutical company Radient Pharmaceuticals Corporation (NYSE Amex: RPC) announced today the following update to its press release dated Monday, November 30, 2009 and entitled "Radient Pharma Completes Registered Direct Offering For Approximately $1 Million."
› Verified 6 days ago
Entity Name | Guthrie Medical Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962451153 PECOS PAC ID: 6002728656 Enrollment ID: O20040301000571 |
News Archive
By shifting a normal protective mechanism into overdrive, a University of Wisconsin-Madison scientist has completely shielded mice from a toxic chemical that would otherwise cause Parkinson's disease.
Scientists have identified a channel present in many pain detecting sensory neurons that acts as a 'brake', limiting spontaneous pain. It is hoped that the new research, published today [22 January] in the Journal of Neuroscience, will ultimately contribute to new pain relief treatments.
"The National Institutes of Health announced Tuesday that it has suspended funding new human embryonic stem cell research and that all federally funded experiments already underway will be cut off when they come up for renewal if a new court order is not overturned. The announcement - which confirmed fears among proponents that the ruling would result in a comprehensive freeze in federal support for stem cell research - came in response to a court order Monday barring the government from funding the research because it involves the destruction of embryos.
Today, the International and American Associations for Dental Research (IADR/AADR) published a paper titled "-catenin is Required in Odontoblasts for Tooth Root Formation." The paper, written by lead authors Tak-Heun Kim and Cheol-Hyeon Bae, Chonbuk National University Korea School of Dentistry, Laboratory for Craniofacial Biology, is published in the IADR/AADR Journal of Dental Research.
US-based pharmaceutical company Radient Pharmaceuticals Corporation (NYSE Amex: RPC) announced today the following update to its press release dated Monday, November 30, 2009 and entitled "Radient Pharma Completes Registered Direct Offering For Approximately $1 Million."
› Verified 6 days ago
Entity Name | St Joseph Regional Health Network |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396786414 PECOS PAC ID: 1658289517 Enrollment ID: O20040414001053 |
News Archive
By shifting a normal protective mechanism into overdrive, a University of Wisconsin-Madison scientist has completely shielded mice from a toxic chemical that would otherwise cause Parkinson's disease.
Scientists have identified a channel present in many pain detecting sensory neurons that acts as a 'brake', limiting spontaneous pain. It is hoped that the new research, published today [22 January] in the Journal of Neuroscience, will ultimately contribute to new pain relief treatments.
"The National Institutes of Health announced Tuesday that it has suspended funding new human embryonic stem cell research and that all federally funded experiments already underway will be cut off when they come up for renewal if a new court order is not overturned. The announcement - which confirmed fears among proponents that the ruling would result in a comprehensive freeze in federal support for stem cell research - came in response to a court order Monday barring the government from funding the research because it involves the destruction of embryos.
Today, the International and American Associations for Dental Research (IADR/AADR) published a paper titled "-catenin is Required in Odontoblasts for Tooth Root Formation." The paper, written by lead authors Tak-Heun Kim and Cheol-Hyeon Bae, Chonbuk National University Korea School of Dentistry, Laboratory for Craniofacial Biology, is published in the IADR/AADR Journal of Dental Research.
US-based pharmaceutical company Radient Pharmaceuticals Corporation (NYSE Amex: RPC) announced today the following update to its press release dated Monday, November 30, 2009 and entitled "Radient Pharma Completes Registered Direct Offering For Approximately $1 Million."
› Verified 6 days ago
Entity Name | St Joseph Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184754657 PECOS PAC ID: 3779688650 Enrollment ID: O20070421000011 |
News Archive
By shifting a normal protective mechanism into overdrive, a University of Wisconsin-Madison scientist has completely shielded mice from a toxic chemical that would otherwise cause Parkinson's disease.
Scientists have identified a channel present in many pain detecting sensory neurons that acts as a 'brake', limiting spontaneous pain. It is hoped that the new research, published today [22 January] in the Journal of Neuroscience, will ultimately contribute to new pain relief treatments.
"The National Institutes of Health announced Tuesday that it has suspended funding new human embryonic stem cell research and that all federally funded experiments already underway will be cut off when they come up for renewal if a new court order is not overturned. The announcement - which confirmed fears among proponents that the ruling would result in a comprehensive freeze in federal support for stem cell research - came in response to a court order Monday barring the government from funding the research because it involves the destruction of embryos.
Today, the International and American Associations for Dental Research (IADR/AADR) published a paper titled "-catenin is Required in Odontoblasts for Tooth Root Formation." The paper, written by lead authors Tak-Heun Kim and Cheol-Hyeon Bae, Chonbuk National University Korea School of Dentistry, Laboratory for Craniofacial Biology, is published in the IADR/AADR Journal of Dental Research.
US-based pharmaceutical company Radient Pharmaceuticals Corporation (NYSE Amex: RPC) announced today the following update to its press release dated Monday, November 30, 2009 and entitled "Radient Pharma Completes Registered Direct Offering For Approximately $1 Million."
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Theresa Erin Yurkonis, DO 2500 Bernville Rd, Reading, PA 19605-9453 Ph: (610) 378-2000 | Dr Theresa Erin Yurkonis, DO 2500 Bernville Rd, Reading, PA 19605-9453 Ph: (610) 378-2000 |
News Archive
By shifting a normal protective mechanism into overdrive, a University of Wisconsin-Madison scientist has completely shielded mice from a toxic chemical that would otherwise cause Parkinson's disease.
Scientists have identified a channel present in many pain detecting sensory neurons that acts as a 'brake', limiting spontaneous pain. It is hoped that the new research, published today [22 January] in the Journal of Neuroscience, will ultimately contribute to new pain relief treatments.
"The National Institutes of Health announced Tuesday that it has suspended funding new human embryonic stem cell research and that all federally funded experiments already underway will be cut off when they come up for renewal if a new court order is not overturned. The announcement - which confirmed fears among proponents that the ruling would result in a comprehensive freeze in federal support for stem cell research - came in response to a court order Monday barring the government from funding the research because it involves the destruction of embryos.
Today, the International and American Associations for Dental Research (IADR/AADR) published a paper titled "-catenin is Required in Odontoblasts for Tooth Root Formation." The paper, written by lead authors Tak-Heun Kim and Cheol-Hyeon Bae, Chonbuk National University Korea School of Dentistry, Laboratory for Craniofacial Biology, is published in the IADR/AADR Journal of Dental Research.
US-based pharmaceutical company Radient Pharmaceuticals Corporation (NYSE Amex: RPC) announced today the following update to its press release dated Monday, November 30, 2009 and entitled "Radient Pharma Completes Registered Direct Offering For Approximately $1 Million."
› Verified 6 days ago
Dr. Robin E. Savar, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3970 Perkiomen Ave, Suite 102, Reading, PA 19606 Phone: 610-779-1330 Fax: 610-779-7699 | |
Mark Elliot Wagner, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 623 North 5th Street, Reading, PA 19601 Phone: 610-374-8585 Fax: 610-374-2574 | |
Joseph Kang, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 131 N 5th St, Reading, PA 19601 Phone: 610-375-8507 Fax: 610-374-5249 | |
Dr. Thomas Hanz Noller, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 526 Penn St, Ste 2, Reading, PA 19602 Phone: 610-375-3000 Fax: 610-898-1149 | |
Leslie Marie Lazore-mack, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1903 Morgantown Rd, Reading, PA 19607 Phone: 610-777-4040 Fax: 610-777-5575 | |
Pearl N Pakdi, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2500 Bernville Rd, Reading, PA 19605 Phone: 610-378-2000 Fax: 610-378-2799 | |
Claire Murphy, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 400 Saint Bernardine St, Alvernia University, Health & Wellness Center, Veronica, Reading, PA 19607 Phone: 610-568-1467 Fax: 610-796-8422 |